《口腔颌面外科杂志》 ›› 2022, Vol. 32 ›› Issue (5): 284-291. doi: 10.3969/j.issn.1005-4979.2022.05.004

• 基础研究 • 上一篇    下一篇

CXCL2-CXCR2轴在血管内皮细胞趋化循环纤维细胞过程中的作用研究

庞楠1(), 王艳2(), 李学拥3   

  1. 1.延安大学咸阳医院口腔科,陕西 咸阳 712000
    2.空军军医大学第三附属医院口腔颌面肿瘤科,陕西 西安 710032
    3.空军军医大学第二附属医院烧伤整形科,陕西 西安 710038
  • 收稿日期:2021-10-15 修回日期:2022-05-17 出版日期:2022-10-28 发布日期:2022-10-31
  • 通讯作者: 王 艳,主治医师. E-mail: 309933400@qq.com
  • 作者简介:

    庞 楠(1982—),男,山西人,博士,主治医师. E-mail:

  • 基金资助:
    国家高技术研究发展计划(2015AA020313)

The role of CXCL2-CXCR2 axis in chemotaxis of circulating fibrocytes by vascular endothelial cells

PANG Nan1(), WANG Yan2(), LI Xueyong3   

  1. 1. Department of Stomatology, Xianyang hospital, Yan′an University, Xianyang 712000, Shaanxi Province
    2. Department of Oral and Maxillofacial Oncology, the Third Affiliated Hospital of Air Force Military Medical University, Xi′an 710032, Shaanxi Province
    3. Department of Burn and Plastic Surgery, the Second Affiliated Hospital of Air Force Military Medical University, Xi′an 710038, Shaanxi Province, China
  • Received:2021-10-15 Revised:2022-05-17 Online:2022-10-28 Published:2022-10-31

摘要:

目的:探讨人CXC趋化因子配体2[chemokine (C-X-C motif) ligand 2,CXCL2]及其受体CXC趋化因子受体2 [chemokine (C-X-C) receptor 2,CXCR2],即CXCL2-CXCR2轴,在血管内皮细胞(vascular endothelial cells, VECs)趋化循环纤维细胞(circulating fibrocytes, CFs)中的作用。方法:将人CFs与人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVECs)在Transwell小室内共培养;用基因芯片技术检测共培养后上调的趋化因子,并筛选出CXCL2、CC趋化因子配体23[chemokine (C-C motif) ligand 23,CCL23]、CXC趋化因子配体16[chemokine (C-X-C motif) ligand 16,CXCL16] 3种趋化因子;然后利用实时定量聚合酶链反应(real-time quantitative polymerase chain reaction,RT-qPCR)、酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)、蛋白质印迹法(Western blotting)进一步筛选共培养后上调的趋化因子及其受体;最后采用趋化因子及趋化因子受体阻断实验明确在VECs趋化循环纤维细胞过程中起作用的趋化因子及其受体。结果:HUVECs与CFs共培养后,CCL23的mRNA表达水平上调;CXCL2的mRNA表达水平及蛋白表达水平均发生了显著上调。同时,CXCR2的mRNA表达水平及蛋白表达水平也发生了显著上调。趋化因子阻断实验表明,在2种细胞的Transwell共培养体系内分别添加CXCL2及CXCR2的多克隆抗体后,发生迁移的人CFs数量明显减少。结论:CXCL2-CXCR2轴可能在VECs趋化CFs的过程中起一定的正向调节作用。

关键词: 颌面部创伤, 血管新生, 血管内皮细胞, 循环纤维细胞, 趋化

Abstract:

Objective: To investigate the role of human chemokine(C-X-C motif) ligand 2(CXCL2) and its receptor chemokine(C-X-C) receptor 2(CXCR2) in chemotaxis of circulating fibrocytes(CFs) by vascular endothelial cells (VECs). Methods: Human CFs and human umbilical vein endothelial cells (HUVECs) were co-cultured in the Transwell plate. The up-regulated chemokines after co-culture were detected by gene chip technology, and three chemokines CXCL2, chemokine (C-C motif) ligand 23 (CCL23), chemokine (C-X-C motif) ligand 16 (CXCL16) were screened out, and then real-time quantitative polymerase chain reaction (RT-qPCR), enzyme-linked immunosorbent assay (ELISA) and Western blotting were utilized to further screen the up-regulated chemokines and their receptors after co-culture. Finally, the chemokine and chemokine receptor blocking experiments were used to confirm the chemokine-receptor axis, which might play a role in the chemotaxis of CFs by VECs. Results: After HUVECs were co-cultured with CFs, the mRNA expression level of CCL23 was up-regulated; the mRNA expression level and protein expression level of CXCL2 were significantly up-regulated. At the same time, the mRNA expression level and protein expression level of CXCR2 were significantly up-regulated. Chemokines blocking experiments showed that after adding CXCL2 and CXCR2 polyclonal antibodies in the Transwell co-culture system of the two cells, the number of migrating human CFs was significantly reduced. Conclusion: The CXCL2-CXCR2 axis may play a positive regulatory role in the chemotaxis of CFs by VECs.

Key words: maxillofacial trauma, angiogenesis, vascular endothelial cells, circulating fibrocytes, chemotaxis

中图分类号: